Aspiration Pneumonia

The Parkinson's Foundation has issued new recommendations to improve the standard of care for hospitalization among individuals with Parkinson’s disease.

Use of glucagon-like peptide-1 receptor agonists was associated with an increased risk for gastric food retention during single endoscopic procedures, although this risk was low when combined with colonoscopy, according to research.

The explosive popularity of glucagon-like peptide-1 receptor agonists for diabetes and weight loss may have revolutionized obesity management, but their widespread use has also sparked concerns — and ignited a turf war — in the endoscopy suite.

Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and likely superior to fasting for safety, and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress.

Glucagon-like peptide-1 receptor agonists were linked to a significantly higher risk for aspiration pneumonia after gastrointestinal endoscopy, particularly among those undergoing upper endoscopy and propofol sedation, according to a study.

Aspiration pneumonia is a common diagnosis among patients seen in and out of the hospital. Aspiration pneumonia is estimated to occur in 5% to 15% of patients with community-acquired pneumonia (CAP); however, standard diagnostic criteria for aspiration pneumonia are lacking. Aspiration is the result of impaired swallowing, allowing oral or gastric contents — or both — to enter the lungs. Following an aspiration event, the pathology varies from pneumonitis to pneumonia, lung abscesses or empyema.